14 封面專題 • COVER STORY 澳大新語 • 2024 UMAGAZINE 30 resources in the Chinese medicine industry’s supply chain to drive the development of the Chinese medicine sector in Macao. Prof Li Peng, deputy director of ICMS and director of MCR&DCM, explains that MCR&DCM is dedicated to supporting the diversification of Macao’s economy. To this end, the centre has collaborated with leading pharmaceutical companies on over 20 projects. These projects include developing traditional formulas such as Baoyuan Decoction (to improve vitality), Banxia Xiexin Decoction (to improve digestion), and Astragalus and Cinnamon Twig Decoction (to improve circulation); popular remedies such as Zishen Yutai Pills and Xiaoer Qixing Cha; and health products such as Ganoderma spore oil and Agaricus bisporus polysaccharides. The centre has also facilitated the introduction of products such as Ganoderma lucidum spore oil soft capsules, developed by GPHL International, into the Macao market. Prof Li Peng adds that with the rapid development of a medical innovation platform characterised by independent intellectual property rights and Chinese features in the Guangdong-Macao In-depth Cooperation Zone in Hengqin, MCR&DCM is actively partnering with enterprises and research institutions in Hengqin. The centre strives to leverage the advantages of the ‘one country, two systems’ policy and incorporate resources from the mainland to advance the Chinese medicine industry. Providing Chinese Medicine Testing Services Chinese medicine products must undergo rigorous examination and testing before they are launched in the market. To meet Macao’s growing demand for these services, and with the support of the Macao SAR Government, UM commenced creation of the Macao Centre for Testing of Chinese Medicine (MCTCM) in July 2021. MCTCM was established on 12 January 2022, and officially came into operation in November 2024. Distinguished Professor Li Shaoping, deputy director of SKL-QRCM and director of MCTCM, says, ‘The Macao SAR Government and the university place a strong emphasis on Chinese medicine testing. Over the past two years, MCTCM has been committed to building a quality management system, enhancing testing capabilities, fostering partnerships, and expanding service offerings. The centre has also taken part in several testing capability assessments.’ In May 2023, MCTCM’s first testing service—measuring levels of lead, cadmium, arsenic, mercury, and copper 澳大澳門中藥檢測中心 The Macao Centre for Testing of Chinese Medicine at UM
RkJQdWJsaXNoZXIy NzM0NzM2